*Marksans Pharma Ltd.* | *CMP* Rs. 54 | *M Cap* Rs. 2210 Cr | *52 W H/L* 57/10
(Nirmal Bang Retail Research)
*Result has improved*
Revenue from Operations came at Rs. 356.5 Cr (7.6% QoQ, 39% YoY) vs QoQ Rs. 331.2 Cr, YoY Rs. 256.4 Cr
EBIDTA came at Rs. 83.2 Cr (18.8% QoQ, 147.7% YoY) vs QoQ Rs. 70 Cr, YoY Rs. 33.6 Cr
EBITDA Margin came at 23.3% vs QoQ 21.1%, YoY 13.1%
Adj. PAT came at Rs. 50.7 Cr vs QoQ Rs. 49.4 Cr, YoY Rs. 25.7 Cr
Quarter EPS is Rs. 1.2
Share is trading at P/E of 12.8x TTM EPS